July 2026
M	T	W	T	F	S	S
	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Metformin for Longevity? Joseph Raffaele Explains Why Context Matters

Joseph Raffaele, MD/LinkedIn

Nov 13, 2025, 01:14

Metformin for Longevity? Joseph Raffaele Explains Why Context Matters

Joseph Raffaele, Physician-Scientist in Longevity Medicine, CEO of PhysioAge LLC, posted on LinkedIn:

”Metformin was supposed to be the longevity drug.

The data isn’t as clean as we hoped.

The longevity space has long hailed metformin as a promising geroprotector. The TAME trial (Targeting Aging with Metformin) aimed to prove it could delay multiple age-related diseases.

But recent evidence suggests the story is more complicated.

What we know:

Metformin activates AMPK, improving insulin sensitivity and reducing inflammation
Observational studies showed diabetics on metformin lived longer than expected
Animal studies demonstrated lifespan extension in certain models

What we’re learning:

A recent Cell Metabolism study found that in non-diabetic individuals engaged in regular exercise, metformin:

Blunted mitochondrial adaptations to training
Reduced VO₂ max gains by 30% compared to placebo
Impaired muscle protein synthesis responses

Another 2023 study showed metformin reduced NAD+ levels in skeletal muscle, potentially accelerating some aspects of metabolic aging.

My clinical POV?

Metformin isn’t inherently “good” or “bad,” it’s context-dependent.

Who it can benefit: Pre-diabetic or insulin-resistant patients, sedentary individuals at high risk for type 2 diabetes, or those with strong family history of diabetes or metabolic syndrome.

Who should think twice: Highly active individuals optimizing athletic performance, lean or metabolically healthy people with low insulin resistance, and those already struggling with low NAD+ or mitochondrial function.

This is why individualised testing and monitoring matter more than headlines.

Follow Joseph Raffaele for evidence-based perspectives on what’s actually working in longevity medicine beyond the hype, grounded in 25 years of clinical practice.

References here and here.”

Metformin